Attitudinal and socio-structural determinants of cervical cancer screening and HPV vaccination uptake: a quantitative multivariate analysis by Kuitto, Kati et al.
www.ssoar.info
Attitudinal and socio-structural determinants of
cervical cancer screening and HPV vaccination
uptake: a quantitative multivariate analysis
Kuitto, Kati; Pickel, Susanne; Neumann, Henning; Jahn, Detlef; Metelmann,
Hans-Robert
Postprint / Postprint
Zeitschriftenartikel / journal article
Zur Verfügung gestellt in Kooperation mit / provided in cooperation with:
www.peerproject.eu
Empfohlene Zitierung / Suggested Citation:
Kuitto, K., Pickel, S., Neumann, H., Jahn, D., & Metelmann, H.-R. (2010). Attitudinal and socio-structural determinants
of cervical cancer screening and HPV vaccination uptake: a quantitative multivariate analysis. Journal of Public Health,
18(2), 179-188. https://doi.org/10.1007/s10389-009-0308-z
Nutzungsbedingungen:
Dieser Text wird unter dem "PEER Licence Agreement zur
Verfügung" gestellt. Nähere Auskünfte zum PEER-Projekt finden
Sie hier: http://www.peerproject.eu Gewährt wird ein nicht
exklusives, nicht übertragbares, persönliches und beschränktes
Recht auf Nutzung dieses Dokuments. Dieses Dokument
ist ausschließlich für den persönlichen, nicht-kommerziellen
Gebrauch bestimmt. Auf sämtlichen Kopien dieses Dokuments
müssen alle Urheberrechtshinweise und sonstigen Hinweise
auf gesetzlichen Schutz beibehalten werden. Sie dürfen dieses
Dokument nicht in irgendeiner Weise abändern, noch dürfen
Sie dieses Dokument für öffentliche oder kommerzielle Zwecke
vervielfältigen, öffentlich ausstellen, aufführen, vertreiben oder
anderweitig nutzen.
Mit der Verwendung dieses Dokuments erkennen Sie die
Nutzungsbedingungen an.
Terms of use:
This document is made available under the "PEER Licence
Agreement ". For more Information regarding the PEER-project
see: http://www.peerproject.eu This document is solely intended
for your personal, non-commercial use.All of the copies of
this documents must retain all copyright information and other
information regarding legal protection. You are not allowed to alter
this document in any way, to copy it for public or commercial
purposes, to exhibit the document in public, to perform, distribute
or otherwise use the document in public.
By using this particular document, you accept the above-stated
conditions of use.
Diese Version ist zitierbar unter / This version is citable under:
https://nbn-resolving.org/urn:nbn:de:0168-ssoar-203650
ORIGINAL ARTICLE
Attitudinal and socio-structural determinants of cervical cancer
screening and HPV vaccination uptake: a quantitative
multivariate analysis
Kati Kuitto & Susanne Pickel & Henning Neumann &
Detlef Jahn & Hans-Robert Metelmann
Received: 22 February 2009 /Accepted: 24 November 2009 /Published online: 5 February 2010
# Springer-Verlag 2010
Abstract
Aim The introduction of the human papillomavirus (HPV)
vaccine enables for the first time in the history of cancer
prevention the possibility of combating the major cause of a
cancer even before its onset. The secondary prevention
measure of cervical cancer screening has thus been
complemented by a primary prevention measure. The aim
of this study is to analyse the determinants of uptake of
preventive measures against cervical cancer as a basis for
comparing the determinants of screening attendance with
those of HPV vaccination attendance.
Subject and methods A population-based representative
survey comprising 760 randomly selected women aged 14
to 65 was performed in the German federal state of
Mecklenburg-Western Pomerania. Prevention behaviour,
attitudes towards cervical cancer screening and HPV
vaccination, and knowledge about cervical cancer and
HPV were investigated by means of a structured question-
naire. Descriptive analyses andmultivariate logistic regression
analyses were conducted to identify the determinants of
screening and HPV vaccine uptake.
Results Attendance both at screening and at HPV vaccina-
tion was best predicted by attitudinal factors. Positive
connotations of cancer prevention measures and utility
expectations, fear of cancer and high subjective risk
perception were conducive to attendance at screening and
HPV vaccination. Screening attendance was less regular
among women of lower socioeconomic status. In contrast,
HPV vaccination uptake was higher for young women with
lower educational attainment and lower social class.
Knowledge did not impact prevention behaviour signifi-
cantly. There is no trade-off between screening and
vaccination attendance; the vast majority of respondents
was aware of the necessity of regular screening attendance
even when vaccinated against HPV.
Conclusions Uptake rates for existing primary and secondary
prevention measures against cervical cancer can be enhanced
by fostering perceptions of utility and positive connotations of
regular screening and becoming vaccinated against HPV.
Elderly women in particular should be encouraged to attend
screening by means of a recall system. Given the low overall
level of knowledge about cervical cancer and its risk factors,
there is a need for education about the necessity and utility of
prevention to reach women of all social classes.
Keywords Cervical cancer prevention . Cervical screening .
HPV vaccination . Attitudes . Socio-structural determinants
Introduction
Since 1971, women in Germany have been entitled to an
annual gynaecological examination for early detection of
cervical cancer and its preliminary stages. The cervical
cancer screening programme is covered by the statutory
health insurance for women aged 20 and up, and includes a
gynaecological examination and a cytological (Pap) smear.
Yet Germany is one of the countries with the highest
mortality and incidence rates for cervical cancer in Western
Europe (Klug et al. 2005). This might be due to the fact that
approximately only 50 percent of women go for regular
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screening (Robra and Dierks 1990; Junge et al. 1992;
Schenck and von Karsa 2000; Klug et al. 2005; Marquardt
et al. 2007). A longitudinal study on the basis of cytological
Pap smear tests in the federal state of Mecklenburg-Western
Pomerania shows that more than 50 percent of women with
invasive cervical cancer diagnosis had not attended screen-
ing in the 5 years preceding the diagnosis, and another 30
percent had attended irregularly (Marquardt et al. 2007).
The study impressively demonstrates the link between non-
attendance at screening and developing invasive cervical
cancer.
Although studies on causes of attendance and non-
attendance at screening do exist, very few are based on
representative data for women of different ages, and
multicausality is not taken into account. Some studies
suggest that women of higher socioeconomic status attend
screening more regularly than women of lower socioeco-
nomic status (Kahl et al. 1999). The role of fear or anxiety
is controversial. While most studies consider fear to be a
barrier for screening attendance, others suggest that anxiety
is predictive of higher screening attendance (e.g. Consedine
et al. 2004 for review of studies on the effects of fear on
breast cancer screening). A lack of awareness of risk factors
and prevention options is also believed to correlate with
lower uptake (Waller et al. 2004; Fylan 1998). Knowledge
of cervical cancer and human papillomavirus (HPV) tends
to be low overall, as various studies have shown (Baer et al.
2000; Dell et al. 2000; Klug et al. 2005).
Since the autumn of 2006, women have had the option to
seek vaccination against HPV. Infection with HPV is the
main risk factor for developing cervical cancer and also a
sine qua non (Walboomers et al. 1999; Herrero and Munoz
1999). For the first time in the history of cancer prevention,
it is now possible to combat cancer and its precursor
stages even before its onset. As various HPV types are also
a causative factor for several others forms of cancer
(oropharyngeal, anal, penile, vulvar and vaginal cancers),
the vaccination truly marks a milestone in cancer preven-
tion research (Centers for Disease Control and Prevention
2008; Metelmann et al. 2007a, b). Since March 2007, HPV
vaccination against the virus types causing cervical cancer
has been officially recommended for girls aged 12–17 by
the Ständige Impfkommision STIKO (German Standing
Vaccination Committee). Statutory health insurance pro-
viders cover the cost of HPV vaccination for this age group
and beyond, in some cases up to the age of 26. As all
authorities and professional associations underline, annual
screening attendance is necessary despite vaccination
because of the residual risk of becoming infected with
other potentially carcinogenic HPV types not covered by
the vaccine and because of the possibility of having been
infected with the high-risk HPV types prior to vaccination
(BVF/DGGG 2007).
The availability of vaccination against a causative factor
for cervical cancer opens up a multitude of questions and
possibilities for an effective prevention strategy. The most
crucial issue is to implement the new HPV vaccination in a
manner that complements screening in the most effective
way. As Hill and Wakefield pointed out in a recent paper,
we can identify suitable measures for an effective preven-
tion strategy and benefit from the available primary and
secondary prevention measures only if we know which
factors help or hinder uptake of cervical cancer prevention
measures (Hill and Wakefield 2008).
The study presented in this paper therefore analyses the
determinants of cervical cancer screening and HPV vacci-
nation uptake on the basis of a representative survey among
760 women in the German federal state of Mecklenburg-
Western Pomerania. Our analysis focuses on whether the
determinants of screening uptake differ from those of HPV
vaccination uptake, identifying and comparing the factors
that increase and reduce uptake of these two preventive
measures.
Model for explaining uptake of preventive measures
Health behaviour is a complex psycho-social phenomenon
that is influenced by a multitude of factors. Studies in the
field of health psychology and medical sociology have
developed models for explaining health behaviour overall.
Our investigations draw mainly on rationalist models to
identify potential key determinants of cervical cancer
screening and HPV vaccination uptake. In general, ratio-
nalist approaches stress the importance of individual cost-
benefit calculations related to certain behaviour on the one
hand and the appraisal of prevailing social norms and
expectations on the other hand. One of the most influential
approaches for explaining preventive behaviour is the
health belief model developed in the 1950s (Rosenbrock
and Michel 2007; Rutter and Quine 2002). The model was
developed in response to low uptake rates for screening,
and was intended as a means of explaining and predicting
uptake of screening and vaccination programmes. Starting
from rationalist assumptions, the health belief model
stresses the impact of subjective risk perception for a
particular disease in terms of perception of the utility of a
change in behaviour and existing barriers to the change of
behaviour. The importance of subjective risk perception is
also stressed by the risk perception and optimistic bias
approach (Rutter and Quine 2002). Later, the health belief
model was enhanced by the use of demographic factors
(age, gender, ethnicity), sociopsychological and socio-
economic variables (personality traits, social class, peer
groups) and catalysts for action (prevention campaigns,
media reporting and education by medical professionals)
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(Rosenbrock and Michel 2007; Rutter and Quine 2002).
Other models, including those based on the theory of
planned behaviour (Ajzen 1988) and the theory of social
comparison (Festinger 1954), point to the importance of the
social component in health behaviour. According to these
models, behaviour is strongly related to perceptions of
social desirability and acceptance.
Another influential model widely used in studies of
health services utilisation, the Andersen behavioural model,
suggests that health service utilisation is determined by
predisposing factors (socio-demographic variables and
health beliefs), enabling factors (personal and societal
resources) and need factors (perceived or evaluated illness
or impairment-related conditions) (Andersen and Newman
1973; Andersen 1995).
Drawing on these approaches, we developed the model
for explaining prevention behaviour shown in Fig. 1.
According to our analytical focus, the dependent variable
prevention behaviour refers to both cervical cancer screen-
ing uptake and HPV vaccination uptake. Socio-structural
determinants include age, education, subjectively perceived
social class, residential size and setting (urban vs. rural),
and distance to gynaecologist. The latter two determinants
are of particular potential interest in the context of
Mecklenburg-Western Pomerania; the concentration of
physicians is low, especially in rural areas, and distances
to doctors may be long. Going by previous studies, we
would expect screening and vaccination uptake to be lower
for older respondents, respondents with low educational
attainment and low socioeconomic status. While education
and socioeconomic status are strongly correlated, our
sample showed only moderate correlation (rho 0.266**)
between these two variables.
Attitudes sum up fear of cancer, attitudes towards health
in general (willingness/readiness to engage in health-
promoting behaviour), attitudes towards cancer prevention
in general (connotations of the utility of preventive
measures and fears associated with attendance) and atti-
tudes towards the preventive measures against cervical
cancer (screening and HPV vaccination). For the latter,
factor analysis revealed that a question on consideration of
screening versus HPV vaccination loaded in three distinct
items: “pro HPV vaccination” attitudes (advantages und
utility of HPV vaccination), “HPV vaccination scepticism”
(sceptical perceptions of the additional value of HPV
vaccination for the prevention of cervical cancer) and “pro
Pap smear” (advantages and necessity of Pap smear
regardless of HPV vaccination). For predicting HPV
vaccination uptake, we added attitudes in relation to
dissemination of vaccination coverage (HPV vaccination
should be offered in schools and/or by local health
authorities) and a variable measuring opinions as to who
should ultimately be responsible for immunisation protec-
tion through vaccination (the state versus the individual).
The last variable is of interest in the special context of
Mecklenburg-Western Pomerania, which was part of the
former German Democratic Republic (GDR). Until 1990,
the state offered centralised health services for free, and a
widespread immunisation programme was backed by pro-
vaccination attitudes among the population. It is of interest
to note whether these experiences are associated with
greater acceptance of the HPV vaccination in our sample.
In general, we would expect positive attitudes towards
prevention measures to have a positive impact on preven-
tion behaviour.
Knowledge about cervical cancer, prevention of cervical
cancer and—in case of uptake and acceptance of HPV
vaccination—knowledge about the HPV vaccination were
included in the model as well. Knowledge about the cancer
and its prevention is expected to influence the individual
cost-benefit calculations for attendance at prevention
measures. Informed women are also more likely to have
been exposed to statements on the desirability of attending
for screening or seeking vaccination, and are thus more
likely to be more aware of positively connoted social norms
associated with participating in preventive measures. We
would thus expect a positive impact of knowledge on
prevention behaviour.
Subjective risk perception was identified by asking
whether respondents would rate their own risk of develop-
ing as likely, unlikely or unthinkable. In accordance with
the risk perception and optimistic bias model, we expect
respondents to be more likely to attend for preventive
measures the higher their subjective risk perception.
Our study also investigates whether screening uptake has
an impact on vaccination attendance and vice versa, that is,
whether regular screeners are more or less likely to seek
vaccination against HPV, or whether women who have
been vaccinated against HPV or are going to seek
















Fig. 1 Theoretical model for explaining prevention behaviour
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looks at whether smoking is associated with more careless
prevention behaviour. These three variables account for
health behaviour.
Data and methods
This study is based on representative survey data. Seven
hundred sixty randomly selected women aged 14 to 65 living
in the German federal state of Mecklenburg-Western
Pomerania were interviewed by telephone in February 2008.
The data pool included all private households with a telephone
connection in Mecklenburg-Western Pomerania. The sample
was drawn on the basis of threefold stratified random sample
design. The telephone numbers were thereby generated
arbitrarily per computer programme and dialled at all times
of the day. The women’s screening and vaccination behaviour,
attitudes towards specific and general heath preventive
measures, and knowledge of cervical cancer and of HPV
were investigated by means of a structured questionnaire.
Socioeconomic characteristics such as education, income and
social class were included. The survey was preceded by a
pretest with 30 interview partners in order to test the suitability
of the questionnaire. The interviewees demonstrated great
interest in the topics of the questionnaire—a fact that might be
reflected in the very low drop-out rate of 0.9 percent, although
the survey included also some rather intimate questions about
the respondents’ sexual behaviour.
Descriptive statistics with contingency tables and chi-
squared testing was done to identify differences in uptake
rates and attitudes in different age and socioeconomic
groups. Causal analysis of the determinants of screening
and HPV vaccination uptake was then performed using
multivariate logistic regression.
Results
Uptake of cervical cancer screening and HPV vaccination
across age and socioeconomic groups
Distribution of respondents by age group, subjectively
evaluated socioeconomic status and educational attainment
is shown in Table 1. To investigate screening uptake,
respondents were asked “When did you have your last
appointment with a gynaecologist for cervical cancer
screening including a Pap smear?”. Table 1 sums up the
rates for regular screening attendance (i.e. within the last
12 months) and for irregular screening attendance (i.e. the last
screening took place more than 3 years ago or never).
Compared with earlier results for Germany (Schenck and
von Karsa 2000) and for the federal state of Mecklenburg-
Western Pomerania (Marquardt et al. 2007), our sample
shows a fairly high rate of women reporting attendance at
screening within the recommended interval of 12 months,
namely 72.8 percent; 13.1 percent of respondents count as
irregular screeners. Chi-squared tests reveal differences in
screening attendance rates between different age groups.
Young women aged 18 to 35 were significantly more likely
to attend for regular screening, while the oldest women in our
sample (56–65 years of age) were considerably more likely
to report irregular attendance. Of those respondents who said
their last screening was 3 or more years ago, 66.3 percent
cited good subjective health and 38.1 percent embarrassment
as a reason for not attending for gynaecological examination;
27.7 percent said they keep forgetting to make an appoint-
ment, and 14.7 percent admitted they were afraid of the
possible test results. Screening attendance was also signifi-
cantly lower among women of lower socioeconomic status;
27.0 percent of respondents who described themselves as
working class said they had not attended for screening within
the last 3 years or had not ever undergone screening.
Like socioeconomic status, educational attainment also
has a significant impact on screening attendance. Women
with higher educational attainment tend to attend screening
on a more regular basis. This holds true even if we exclude
from the analysis respondents under the age of 20, who are
more likely to lack educational completion and are not yet
eligible for free annual cervical cancer screening.
When it comes to HPV vaccination attendance, the
respondents were first asked “Have you already been
vaccinated against HPV?” (“HPV vaccination attendance”).
Respondents who answered in the negative were then
asked whether they were planning to seek vaccination
against HPV in the future (“Intended HPV vaccination
attendance”). Both questions are intended to identify
individual behaviour with regard to HPV vaccination as a
preventive measure. In order to map general approval of
vaccination irrespective of the personal utility consider-
ation, respondents were asked whether they would seek
HPV vaccination for their daughter. “HPV vaccination
approval” in Table 1 indicates the proportion of respondents
who said “Yes, I would get my daughter vaccinated
whatever the cost”. As some previous studies have shown,
mothers are broadly in favour of getting their daughters and
also their sons vaccinated against HPV (Waller et al. 2006;
Slomovitz et al. 2006).
Not surprisingly, rates of actual uptake rate for HPV
vaccination as well as vaccination intention are high in the
youngest respondent group (age 14–17), but decline rapidly
in older age groups. At the time of the survey, 68.0 percent
of adolescents aged 14–17 but only 12.7 percent of young
women aged 18–26 were already vaccinated against HPV.
Rather surprisingly, many older women also said they
would consider seeking vaccination against HPV (38.2
percent of women aged 27–35, 30.7 percent of women aged
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36–45, 21.1 percent of women aged 46–55 and 13.2
percent of women aged 56–65). Differences between age
groups are not significant when it comes to approval of
HPV vaccination; 86.0 percent of the youngest respondents
said they would seek vaccination for their daughter
whatever the cost, but the approval rate is also high in the
36–45 and 56–65 age groups.
Unlike screening attendance, HPV vaccination uptake
and approval are not as strongly correlated with socioeco-
nomic status. While the professed intention to seek
vaccination is higher in lower socioeconomic groups, the
differences are not statistically significant, as chi-squared
testing shows. In contrast, approval of HPV vaccination is
significantly higher in higher socioeconomic groups; 61.1
percent of respondents who described themselves as
working class said they would seek HPV vaccination for
their daughter, versus the corresponding figure of 85.3
among upper middle class respondents.
With regard to education, the picture is more mixed.
Group differences are strongly related to respondents’ age,
especially in regard to actual or intended HPV vaccination
uptake. The highest approval rates for HPV vaccination can
be found among respondents without school leaving
qualifications/still at school, and again in respondents with
intermediate or high educational attainment levels. Again,
the differences can also be related to respondents’ age, with
high levels of approval in the group of respondents without
school leaving qualifications/still attending school.
















N % N % N % N % N % N %
Total 760 100.0 551 72.8 99 13.1 50 6.6 197 31.5 506 67.5
Age group
14–17 50 6.6 19 38.0 27 55.1 34 68.0 13 81.3 43 86.0
18–26 118 15.5 102 86.4 7 6.0 15 12.7 53 62.4 74 62.7
27–35 102 13.4 83 82.2 5 5.0 1 1.0 34 38.2 63 62.4
36–45 201 26.5 142 71.0 18 9.0 1 0.5 54 30.7 138 69.0
46–55 144 19.0 109 76.2 11 7.7 0 - 26 21.1 94 66.7
56–65 144 19.0 95 66.4 29 20.3 0 - 18 13.2 94 68.1
X2 for age group difference (df=5) 50.31*** 101.30*** 344.36*** 84.64*** 10.53+
Social class (subjective)
Underclass 38 5.1 21 56.8 10 27.0 0 - 14 38.9 22 61.1
Lower middle class 146 19.6 96 65.8 20 13.7 0 - 42 31.8 90 61.6
Middle class 521 69.8 389 75.0 64 12.4 42 8.1 131 31.6 353 68.9
Upper middle class 33 4.4 28 84.8 4 12.1 8 24.2 4 16.7 29 85.3
Upper class 8 1.1 5 62.5 0 - 0 - 3 42.9 1 14.3
X2 for social class difference (df=4) 12.43* 7.78+ n.a. 3.78 17.33**
Education
No school leaving qualifications/still
at school
58 7.7 26 45.6 27 47.4 37 64.9 16 80.0 50 87.7
Lower secondary 56 7.4 35 62.5 14 25.5 0 - 15 29.4 32 58.2
Upper secondary 409 54.2 310 75.8 42 10.3 10 2.5 112 32.2 265 66.3
Advanced technical certificate 46 6.0 31 67.4 6 13.0 0 - 14 34.1 33 71.7
A-level 186 24.8 146 78.5 10 5.4 3 1.6 40 24.5 123 65.4
X2 for social class difference (df=4) 29.77*** 78.56*** 338.60*** 25.72*** 13.81**
Level of significance: ***p≤0.001; **p≤0.01; *p≤0.05; +p≤0.10
1 Last screening attendance within the last 12 months
2 Last screening attendance more than 3 years ago or never
3 Has been vaccinated against HPV
4 Intends to get vaccinated against HPV
5Would get the daughter vaccinated against HPV in any case
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Results of the multivariate analyses
Model specifications
Multivariate logistic regression analyses were conducted to
test the theoretical model of determinants of screening
attendance and HPV vaccination uptake and approval. For
models predicting regular (within the last 12 months) and
irregular (more than 3 years ago or never) screening
attendance, only respondents aged 20 or older were
included due to the fact that women are eligible to receive
free annual cervical examination including a Pap smear
within the framework of the German cervical cancer
screening programme starting from the age of 20 (Schenck
and von Karsa 2000).
HPV vaccination uptake (already vaccinated/intends to
seek vaccination) was analysed among respondents aged 35
or younger. The official recommendation of the Ständige
Impfkommission STIKO (German Standing Vaccination
Committee) for HPV vaccination applies to adolescent
females aged 12 to 17 (RKI 2007), but some health
insurance providers cover the cost of vaccination for
women up to the age of 26. The best target group for
analysis of HPV vaccination attendance within our sample
would therefore be respondents aged 14–26, but because of
missing data, the number would be too low in this age
group alone. Since older women too can benefit from
vaccination and since the intention to seek vaccination
against HPV is still almost 40 percent in respondents of up
to 35 years of age, we extended our analysis on
determinants of HPV vaccination uptake to include 14 to
35 year olds (Wright et al. 2008). Finally, the whole sample
is included in the model for predicting HPV vaccination
approval (would seek vaccination for daughter at whatever
cost), since approval of the vaccination should not be solely
dependent on considerations of personal utility.
Determinants of screening uptake
The results of the logistic multivariate regressions are
reported in Table 2. Regular screening attendance (Model 1)
was best predicted by attitudinal factors, but also by
sociostructural characteristics and subjective risk appraisal
of the respondents. In contrast, knowledge of cervical
cancer or of the prevention measures was not a significant
predictor of screening behaviour. Women who said they
were afraid of the results of cancer screening were 2.53
times more likely to belong to the regular screening
attendance group. Conversely, an absence of fear was
predictive of non-attendance, although at a lower level of
significance (Model 2). Hence, fear and anxiety seem to
encourage rather than hinder regular screening. Fear of a
diagnosis of cancer is also related to subjective risk
appraisal (rho 0.122**), which in turn is a weakly
significant predictor for regular screening attendance, and
the lack of which is a highly significant predictor for
irregular attendance.
Positive connotations of cancer prevention overall (role
model effect vis-à-vis children or partner, confidence gains
with respect to own state of health through attendance)
proved to be another highly influential factor for predicting
screening attendance (odds ratio OR 1.77). When it comes
to the value of HPV vaccination compared to screening, a
pro-Pap smear attitude and utility beliefs were significantly
related to regular screening attendance (OR 1.87). Yet
respondents who expressed sceptical views about the utility
of HPV vaccination were at the same time somewhat less
likely to belong to the group of regular screeners (OR 0.73).
Hence, it seems more plausible that persons with positive
perceptions about the utility of prevention measures, be
it screening or vaccination, are more likely to go for
screening. There does not seem to be a trade-off between
screening and HPV vaccination at the attitudinal level. Nor
was uptake of HPV vaccination or approval of the
vaccination significantly related to screening behaviour.
The non-existence of a trade-off between screening atten-
dance and HPV vaccination is also supported by the fact
that 89.5 percent of respondents said they would prefer to
take both preventive measures if they had the choice, and
93.9 percent were aware that regular screening is still
necessary even after being vaccinated against HPV. On the
other hand, respondents who expressed pro-HPV vaccina-
tion attitudes were 1.91 times more likely to belong to the
group of irregular screening attendants; this effect was
weakly significant.
Willingness to engage in health-promoting behaviour
such as a healthy diet and regular physical activity was not
significantly associated with regular screening attendance,
but the lack of it was likely to lead to neglect of regular
screening (OR 0.34). Smoking did not have a significant
effect.
Contrary to the bivariate relationship reported earlier,
education did not have a significant impact on screening
behaviour in the multivariate setting. Belonging to a higher
social class was significantly associated with more regular
screening attendance. Though age was a significant
predictor for screening attendance or non-attendance, the
odds were very close to one. Against our expectations,
living in a rural area and distance to the next gynaecologist
did not impact screening attendance, even in a sparsely
populated state like Mecklenburg-Western Pomerania.
Determinants of HPV vaccination attendance and approval
Determinants of HPV vaccination attendance (Model 3)
show similarities to those relating to screening behaviour,
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especially with regard to attitudinal factors. Respondents
who express fear of screening results (OR 4.29), have
positive connotations of cancer prevention measures (OR
2.10) and are willing to invest in their health through
appropriate behaviour (OR 5.76) were significantly more
likely to seek vaccination against HPV. Subjective risk
appraisal was another highly significant predictor of
vaccination uptake. Respondents with a heightened awareness
of their own risk of getting cervical cancer were 5.29 times
more likely to become vaccinated against HPV. However, it is
possible that people already vaccinated or who are considering
vaccination have had their awareness of the risk of developing
cervical cancer raised by a gynaecologist or other physician in
connection with the vaccination procedure, or by more in-
Table 2 Determinants of screening and HPV vaccination attendance and HPV vaccination approval using logistic regressions










Age RC: age group 14–17 0.96** 1.06** 0.87* 1.01
Education RC: no degree/still at school 0.84 0.85 0.56*** 1.01
Subjective social class RC: underclass 1.55* 0.62+ 0.47+ 0.98
Urban residence RC: rural residence 1.10 1.13 7.38*** 0.84
Distance to gynaecologist (in minutes) RC: 0 min 1.00 1.01 1.04 1.00
Subjective risk perception RC: no risk perceived 1.44+ 0.46** 5.29*** 1.15
Knowledge
Knowledge of cervical cancer5 3.14 0.18 0.04+ 12.24**
Knowledge of prevention of cervical cancer5 0.95 1.14 0.04** 1.69
Knowledge of HPV vaccination5 0.82 5.45**
Attitudes
Fear6 2.53** 0.45+ 4.29* 1.67+
Positive connotations of cancer prevention measures6 1.77*** 0.40*** 2.10* 1.13
Willingness to invest in health behaviour6 1.73 0.34* 5.76* 0.69
Pro HPV vaccination6 0.77 1.91* 1.73 1.00
HPV vaccination scepticism6 0.73+ 1.08 0.55 0.49***
Pro Pap smear6 1.87** 0.58 0.81 1.52+
Pro spread of HPV vaccination, e.g., at schools RC:
against spread of vaccination, e.g., at schools
- - 1.29 1.75**
Self-responsibility for immunisation protection RC:
state responsibility
- - 0.91 1.17
Health behaviour
Attendance at HPV vaccination RC: non-attendance/does
not intend to
1.16 0.53 - 2.88***
Approval of HPV vaccination RC: would not get
daughter vaccinated
0.70 1.29 16.55*** -
Attendance at screening RC: irregular/non-attendance - - 0.36 0.71
Smoking RC: does not smoke 0.98 0.49 1.45 0.55*
Constant 0.10 56.97 0.99 0.01*
Nagelkerke R2 0.188 0.301 0.617 0.293
N 485 485 114 477
Odds ratios; level of significance: ***p≤0.001; **p≤0.01; *p≤0.05; +p≤0.10
RC = reference category
1 Last screening attendance within the last 12 months; age 20–65
2 Last screening attendance more than 3 years ago or never; age 20–65
3 Has been vaccinated against HPV or intends to seek vaccination; age 14–35
4Would have their own daughter vaccinated against HPV whatever the cost, etc.; all respondents
5 Variables coded dichotomously in 0 = incorrect knowledge on a given statement (RC) and 1 = correct knowledge
6 Variables coded dichotomously in 0 = does not agree on the given issue (RC) and 1 = agrees on the given issue
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depth engagement with the issue. Thus, we cannot be sure of
the direction of the causalities between risk appraisal and
vaccination attendance.
The impact of knowledge is somewhat puzzling; while
knowledge of HPV vaccination did not have a significant
impact on vaccination attendance, knowledge of cervical
cancer (OR 0.04) and its prevention (OR 0.04) were
associated significantly negatively with HPV vaccination
attendance. As the OR shows, the impact is minimal, however.
HPV vaccination attendance was predicted well by
sociostructural determinants. Not surprisingly, age was
negatively related to uptake of HPV vaccination, although
the statistical relevance of age for prediction of vaccination
attendance is not very high (OR 0.87). The probability of
belonging to the group of actual or potential recipients of
HPV vaccination was positively correlated with low
educational attainment (OR 0.56) and low socioeconomic
status (OR 0.47). Not living in a rural area increased the
odds of HPV vaccination uptake by 7.38. Hence, the place
of residence was the strongest single predictor in the model
apart from approval of HPV vaccination.
Finally, actual uptake of HPV vaccination was very highly
associated with approval of HPV vaccination. Since we would
expect all rational individuals to show high approval of
measures they are willing to undergo, this is hardly surprising.
Running the model without approval did not change the
results significantly. The R2 for the model was lower (0.536),
and sceptical attitudes towards HPV vaccination as well as
screening uptake became weakly significant.
Determinants ofHPV vaccination approval differ decisively
from those of actual vaccination uptake (Model 4). None of the
sociostructural factors had a significant impact, but knowledge
now became highly significant. Overall knowledge about
cervical cancer increased the odds for respondents’willingness
to have their own daughter vaccinated against HPV (OR
12.24). Knowledge of HPV vaccination also had a strong
positive association with approval of the vaccination.
While fear displayed much lower odds for approval of the
vaccination than for the actual prevention behaviour inModels
1–3, it was still positively associated with approval. Respond-
ents in favour of widespread vaccination, e.g. at schools, were
significantly more likely to approve the vaccination (OR
1.75). Logically, subjects attending HPV vaccination them-
selves were highly likely to approve the vaccination. As was
the case for Model 3, running Model 4 without HPV
vaccination produced no significant changes. Finally, smokers
were less likely to evince strong approval of the vaccination.
Discussion
This study is one of the first to analyse uptake of cervical
cancer screening and HPV vaccination as well as their
determinants on the basis of a representative survey of
women of a variety of ages. The main results of the study
show, first, that self-reported attendance at screening during
the 12 months preceding the survey was fairly high in
comparison to previous findings in Germany (Schenck and
von Karsa 2000; Klug et al. 2005; Marquardt et al. 2007),
with more irregular attendance reported by elderly women
in particular. Second, screening attendance was significant-
ly higher among respondents of higher socioeconomic
status and higher educational attainment. Contrary to this,
HPV vaccination reaches also women of lower socioeco-
nomic status and lower educational attainment. HPV
vaccination thus does not only reach upper class clientele
as some critical voices have claimed. Third, HPV vaccina-
tion uptake was high among the primary target group of
young women aged 14–17. At the time of the survey, two-
thirds of women in this age group had been vaccinated
against HPV. Among older cohorts, HPV vaccination
uptake was radically lower, but a rather large number of
respondents even of more advanced ages expressed an
intention to seek vaccination. This is somewhat surprising,
since the main campaign for the HPV vaccination was
targeted mainly at girls and young women, and we cannot
expect women to have detailed medical knowledge on the
utility of the HPV vaccination for older women (for the
utility of the HPV vaccination for women older than
25 years, see e.g. Munos et al. 2009; Harper 2009).
Approval rates for HPV vaccination were very high as
well. Over two-thirds of all respondents said they would
have their daughter vaccinated against HPV irrespective of
cost or other factors.
Fourth and most strikingly, the results of the multivariate
analyses stress the importance of attitudinal factors for
prevention behaviour in general, be it secondary (screening)
or primary prevention (vaccination). Positive connotations
and utility expectations in relation to prevention measures
were important predictors both for screening and HPV
vaccination uptake. Willingness to invest in a healthy
lifestyle in general was significantly related to HPV
vaccination uptake, and the lack of it with irregular
screening attendance. According to our results, fear or
anxiety boosts rather than hinders uptake. This contradicts
the outcome of several earlier studies (Bloom et al. 1987;
Austin et al. 2002; Metelmann 2007). Subjective risk
perception too is a conducive factor. Knowledge did not
impact screening attendance, but ignorance of cervical
cancer was weakly related to seeking vaccination against
HPV. Yet knowledge was positively associated with
approval of HPV vaccination in general. We have to bear
in mind, though, that the detailed knowledge of the
respondents about cervical cancer, its risk factors and
prevention was rather deficient. Thus, the effect of
knowledge might rather be based on the awareness that
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attending preventive measures is positive in general than on
substantiated knowledge of the cancer and its prevention.
For example, it is hard to say whether the elderly women in
our sample who report willingness to get vaccinated against
HPV themselves are really aware of how and under what
circumstances they really can benefit from the HPV
vaccination, or whether they just have heard of a vaccina-
tion against a cancer and are willing to act for their health
by getting vaccinated.
Finally, screening and vaccination attendance did not
show evidence of any trade-offs; attending screening
regularly was not negatively associated with HPV vaccina-
tion uptake, and conversely, vaccination uptake was not
significantly related to more irregular screening attendance.
Rather, the results suggest that positive attitudes towards
prevention measures in general—screening or vaccination
is conducive to prevention behaviour. Given the fact that
almost all respondents were aware of the advisability of
regular screening even after being vaccinated against HPV,
it seems there is little cause to worry that HPV vaccination
might lead to neglect of screening.
This study has some limitations, though. As the number
of respondents in the age group of 14–26 was low, we were
not able to conduct detailed multivariate analyses on
determinants of uptake of the HPV vaccination and
screening in this age group, which would be especially
interesting in view of the German recommendations on
HPV vaccination practice. For example, all sociostructural
factors included in the model explaining vaccination uptake
(Model 3 in Table 2) are more interwoven in the subgroup
of young women than in the whole sample. We must
therefore be cautious in drawing conclusions as to the
relevance of sociostructural factors in this age group. Also,
more specified indicators of actual knowledge of cervical
cancer, risk factors and the mode of operation of the
preventive measures would be needed in order to draw
conclusions about the relationship of knowledge and
prevention behaviour. Further analysis would also be
needed on the relationship between knowledge, attitudes
toward prevention behaviour and utility expectations.
In conclusion, some important policy implications can
be drawn on the basis of the results of this study. The
analysis of attendance at screening and HPV vaccination
across age, social class and educational features shows that,
despite the relatively high rate of yearly uptake of cervical
cancer screening, a considerable proportion of women in
Mecklenburg-Western Pomerania had missed screening in
the year preceding the survey. This is especially true for
elderly women, but also for women aged 36–45. Therefore,
prevention strategies should seek to encourage regular
screening attendance especially among women in age
groups unlikely to be consulting their gynaecologist as a
matter of course for reproductive or menopausal matters.
Since screening attendance seems to be strongly associated
with socioeconomic status, more suitable ways of targeting
lower-income women should be developed. Additionally,
27.7 percent of the respondents who had not attended
screening for over 3 years said they always forget to make
an appointment; a recall system might be helpful.
As a recent global survey of public beliefs and
behaviours relevant to cancer reveals, 82.8 percent of
respondents in high-income countries are optimistic about
possibilities to combat cancer (Hill and Wakefield 2008).
The question is, then, how to translate this optimism into
individual action and regular utilisation of existing preven-
tive measures. In the case of cervical cancer, more precise
information on the necessity of regular screening atten-
dance as well as the utilities of HPV vaccination in different
ages should be provided not only by doctors, but also by
public authorities. It is essential to sensitise women to the
pertinence of screening and HPV vaccination in preventing
cancer. Encouraging positive perceptions of attending
prevention measures should be accorded more attention in
health prevention education.
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